CIRM is governed by 35 dedicated Californians representing patients, researchers and the biotechnology industry whose knowledge, passion and commitment to CIRM’s mission has guided the organization ...

ICOC Governing Board/Application Review Subcommittee June 27, 2024 Transcripts Minutes ...

BACKGROUND: The regulation of gene expression is complex and occurs at many levels, including transcriptional and post-transcriptional, in metazoans. Transcriptional regulation is mainly determined by ...

Sponsored by the California Institute for Regenerative Medicine (CIRM) and hosted by Cedars-Sinai, the 7th Annual Alpha Clinics Network Symposium brings together a wide array of stakeholders, ...

What is the California Institute for Regenerative Medicine (CIRM)? CIRM, California’s Stem Cell Agency, was created by the voters of California in 2004 when they overwhelmingly passed Proposition 71, ...

David Higgins, PhD, earned his PhD in molecular biology and genetics from the University of Rochester in New York, followed by a postdoctoral fellowship at the National Cancer Institute before moving ...

ReMIND-L (DISC4) applications now closed. ReMIND-X applications expected to post in Q4 2024. The mission of the California Institute for Regenerative Medicine (CIRM) is to accelerate world-class ...

Our Agency funds clinical trials testing promising stem cell or gene therapies for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem ...

have the ability to divide and create an identical copy of themselves, a process called self-renewal; and can also divide to form cells that mature into cells that make up every type of tissue and ...

Cranial neural crest cells give rise to ectomesenchymal derivatives such as cranial bones, cartilage, smooth muscle, dentin, as well as melanocytes, corneal endothelial cells, and neurons and glial ...

The CIRM-funded Alpha Clinics form a network of leading medical centers across California, specializing in delivering stem and gene cell clinical trials. The Network’s success is driven by its ability ...